Trials / Terminated
TerminatedNCT00911729
Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
Content Validation of the EORTC QLQ-C30 Version 3.0, and NIH Quality of Life and Symptoms Questionnaire for Pheochromocytoma and Paraganglioma
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (estimated)
- Sponsor
- Molecular Insight Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of two disease-specific questionnaires, and to evaluate how effective these questionnaires are at assessing the quality of life and symptoms of patients with pheochromocytoma or paraganglioma.
Conditions
Timeline
- Start date
- 2009-04-01
- First posted
- 2009-06-02
- Last updated
- 2013-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00911729. Inclusion in this directory is not an endorsement.